Does three-dimensional functional infrared imaging improve breast cancer detection based on digital mammography in women with dense breasts?


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 12 02 2019
accepted: 19 04 2019
revised: 30 03 2019
pubmed: 23 5 2019
medline: 15 1 2020
entrez: 23 5 2019
Statut: ppublish

Résumé

We aimed to estimate the incremental cancer detection rate achieved by adding three-dimensional functional infrared imaging (3DIRI) to digital mammography in women with dense breasts. In this prospective study conducted between December 2014 and April 2016, 1727 women (median age 56) with percentage volumetric breast density > 6% were recruited at routine screening mammography to undergo additional 3DIRI. The 3DIRI findings were classified as negative or positive. Women with a negative mammography but positive 3DIRI were referred to dynamic contrast-enhanced MRI, whereas all other women underwent routine follow-up based on the mammography finding. Diagnosis of breast cancer was verified by histopathologic examination. The number of women diagnosed with a malignancy formed the basis of our statistical analysis. Mammography detected 7 cancers in 7 women. Of 1692 women with negative mammography, 222 women (13%) had a positive 3DIRI of which 219 underwent MRI. An additional 6 cancers were identified in 5 women, increasing the diagnostic yield from 7 of 1727 (0.41%) to 12 of 1727 (0.69%). The incremental cancer detection rate associated with using 3DIRI to select women for MRI was 5 of 222 (22.5 additional cancers per 1000). The use of 3DIRI to select women for an additional MRI can result in the detection of additional cancers in women with dense breasts, but at the expense of additional false positives and considerably lower positive predictive value of the combined examinations. Additional studies are necessary to evaluate the role of 3DIRI as an adjunct to mammography. • Use of three-dimensional functional infrared imaging to select women for an MRI in addition to screening mammography has the potential to improve breast cancer detection in women with dense breasts.

Identifiants

pubmed: 31115623
doi: 10.1007/s00330-019-06248-y
pii: 10.1007/s00330-019-06248-y
pmc: PMC6795638
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6227-6235

Subventions

Organisme : Real Imaging
ID : -

Références

Br J Radiol. 2012 Nov;85(1019):e1074-82
pubmed: 22674710
AJR Am J Roentgenol. 2017 Jan;208(1):222-227
pubmed: 27824483
Eur Radiol. 2007 Dec;17 Suppl 6:F48-51
pubmed: 18376457
Eur Radiol. 2013 Aug;23(8):2061-71
pubmed: 23553585
Breast Cancer. 2017 Jan;24(1):32-41
pubmed: 27138386
Acta Oncol. 2009;48(1):27-33
pubmed: 18767000
Eur J Cancer. 2008 Mar;44(4):539-44
pubmed: 18267357
Eur Radiol. 2013 May;23(5):1191-8
pubmed: 23223805
J Clin Oncol. 2005 Nov 20;23(33):8469-76
pubmed: 16293877
Breast. 2016 Apr;26:119-34
pubmed: 27017251
Clin Radiol. 2009 Jun;64(6):624-7
pubmed: 19414086
Radiology. 2017 May;283(2):361-370
pubmed: 28221097
BMC Cancer. 2009 Sep 20;9:335
pubmed: 19765317
J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):77-81
pubmed: 12585659
JAMA. 2008 May 14;299(18):2151-63
pubmed: 18477782
Magn Reson Imaging. 2017 Jan;35:39-45
pubmed: 27569368
Br J Radiol. 2011 Nov;84(1007):1005-10
pubmed: 22011830
Breast Cancer Res Treat. 2017 Aug;164(3):659-666
pubmed: 28523569
Radiol Med. 2013 Mar;118(2):239-50
pubmed: 22872456
J Natl Cancer Inst. 2000 Jul 5;92(13):1081-7
pubmed: 10880551
Eur Radiol. 2008 Jul;18(7):1307-18
pubmed: 18389253
Clin Breast Cancer. 2016 Dec;16(6):e193-e201
pubmed: 27431459
Yonsei Med J. 2015 Sep;56(5):1352-8
pubmed: 26256979
Int J Epidemiol. 2017 Dec 1;46(6):1740-1741g
pubmed: 28180256
Radiology. 2015 Mar;274(3):663-73
pubmed: 25329763
Eur J Radiol. 2016 Sep;85(9):1554-63
pubmed: 27501888
Eur Radiol. 2001;11(6):965-9
pubmed: 11419172
Radiology. 2002 Oct;225(1):165-75
pubmed: 12355001
Acad Radiol. 2017 Mar;24(3):316-320
pubmed: 27916594

Auteurs

Roxanna J Hellgren (RJ)

Department of Medical Imaging, Division of Breast Imaging, Södersjukhuset, 118 83, Stockholm, Sweden. roxanna.hellgren@sll.se.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77, Stockholm, Sweden. roxanna.hellgren@sll.se.

Ann E Sundbom (AE)

Department of Medical Imaging, Division of Breast Imaging, Södersjukhuset, 118 83, Stockholm, Sweden.

Kamila Czene (K)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77, Stockholm, Sweden.

David Izhaky (D)

Department of Research and Development, Real Imaging, 1 Golan St., 7019802, Airport City, Israel.

Per Hall (P)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77, Stockholm, Sweden.
Department of Oncology, Södersjukhuset, 118 83, Stockholm, Sweden.

Paul W Dickman (PW)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH